5 Biotech Stocks to Buy Today According to Kerr Neilson’s Platinum Asset Management
In this piece, we will take a look at the five biotechnology stocks to buy today according to Kerr Neilson's Platinum Asset Management.
Ideaya Biosciences Inc. (IDYA)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Logos Capital Arsani William | 2,850,000 | $31,892 | +84% | 4.13% |
| 2. | Avidity Partners Management David Witzke And Michael Gregory | 2,690,000 | $30,101 | +6% | 0.62% |
| 3. | Point72 Asset Management Steve Cohen | 1,847,017 | $20,668 | +37% | 0.08% |
| 4. | Biotechnology Value Fund / BVF Inc Mark Lampert | 1,600,559 | $17,910 | 0.71% | |
| 5. | Platinum Asset Management Kerr Neilson | 952,561 | $10,659 | +9% | 0.32% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.32 | 81 | Large Shareholder | 237,475 | 2020-06-30 | Filing | |
| $13.32 | 929 | Large Shareholder | 1,204,981 | 2020-06-30 | Filing | |
| $13.32 | 1,521 | Large Shareholder | 1,667,420 | 2020-06-30 | Filing | |
| $13.93 | 1,354 | Large Shareholder | 237,394 | 2020-06-22 | Filing | |
| $13.93 | 7,854 | Large Shareholder | 1,204,052 | 2020-06-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $26.62 | 1,000 | Officer | 78,789 | 2021-10-04 | Filing | |
| $25.85 | 500 | Officer | 79,789 | 2021-10-04 | Filing | |
| $27.67 | 200 | Officer | 78,789 | 2021-09-08 | Filing | |
| $27.41 | 11,184 | Officer | 78,989 | 2021-09-08 | Filing | |
| $27.46 | 116 | Officer | 78,789 | 2021-09-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 10,100 | $113,019 | 0% | |
| 2. | 2,660,713 | $29,774 | 30.22% | |
| 3. | 2,490,277 | $27,866 | 0% | |
| 4. | 2,249,180 | $25,169 | 0.05% | |
| 5. | 2,202,812 | $24,649 | 1.26% |
News See All
5 Pharmaceutical Stocks to Buy Now According to Billionaire Kerr Neilson
In this article, we will look at 5 pharmaceutical stocks to buy now according to billionaire Kerr Neilson.
Is IDYA A Good Stock To Buy Now?
In this article we will analyze whether IDEAYA Biosciences, Inc.
Here is What Hedge Funds Think About IDEAYA Biosciences, Inc. (IDYA)
In this article we will take a look at whether hedge funds think IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is a good investment right now.
Here’s What Hedge Funds Think About IDEAYA Biosciences, Inc. (IDYA)
We at Insider Monkey have gone over 752 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...
Hedge Fund and Insider Trading News: Bain Capital, Warren Buffett, Eddie Lampert, Ideaya Biosciences Inc (IDYA), Chesapeake Energy Corporation (CHK), Sonic Foundry Inc (SOFO), and More
Bain Capital, the 35-year-old private equity firm known for takeovers of companies like Varsity Brands and the now bankrupt Toys R Us, is raising $1 billion for a new technology fund that will be used...
Billionaire Hedge Funds
